Salivary Cancer Active Not Recruiting Phase 2 Trials for Enzalutamide (DB08899)

IndicationStatusPhase
DBCOND0080787 (Salivary Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02749903Enzalutamide for Patients With Androgen Receptor Positive Salivary CancersTreatment